ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated

February 25, 1977

Critics Told To Back Waste Charges Or Shut Up

November 23, 1974

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

NCI-Approved CTEP Trials For The Month of July

July 27, 2012